Levothyroxine Administration Timing Relative to Other Medications
Levothyroxine should be taken at least 4 hours before or after calcium, iron, antacids, bile acid sequestrants, and proton pump inhibitors to avoid clinically significant absorption interference. 1
Medications Requiring 4-Hour Separation from Levothyroxine
High-Priority Interacting Agents
Calcium supplements and calcium carbonate bind levothyroxine in the gastrointestinal tract, reducing absorption by 30–40%; administer levothyroxine at least 4 hours apart from these agents 1
Iron supplements (ferrous sulfate) similarly bind levothyroxine and delay absorption; maintain a minimum 4-hour separation 1
Bile acid sequestrants (cholestyramine, colestipol, colesevelam) are known to decrease levothyroxine absorption substantially; take levothyroxine at least 4 hours before these drugs or monitor TSH levels closely 2, 1
Proton pump inhibitors (omeprazole, pantoprazole, esomeprazole) reduce gastric acidity, which is essential for levothyroxine tablet dissolution and absorption; this can reduce bioavailability by 30–40% 3, 1
Antacids containing aluminum hydroxide, magnesium hydroxide, or simethicone cause hypochlorhydria and reduce levothyroxine absorption; separate by at least 4 hours 1
Sucralfate affects intragastric pH and reduces levothyroxine absorption; maintain 4-hour separation 1
Medications Requiring Dose Adjustment or Close Monitoring
Drugs That Increase Levothyroxine Metabolism
Rifampin accelerates hepatic metabolism of levothyroxine through enzyme induction, often requiring increased levothyroxine dosing with TSH monitoring 3, 1
Phenobarbital induces hepatic enzymes (UGT), leading to lower T4 serum levels; changes in thyroid status may occur if barbiturates are added or withdrawn 1
Phenytoin and carbamazepine reduce serum protein binding of levothyroxine, and total and free T4 may be reduced by 20–40%; closely monitor thyroid hormone parameters 1
Drugs That Affect Protein Binding
Estrogen-containing oral contraceptives increase thyroxine-binding globulin (TBG), which may necessitate levothyroxine dose increases; however, free T4 and TSH typically remain normal with continued administration 1
Androgens and anabolic steroids decrease serum TBG concentration, potentially affecting total T4 levels while free T4 remains normal 1
High-dose salicylates (>2 g/day) inhibit binding of T4 to TBG and transthyretin, causing an initial increase in free T4 followed by normalization 1
Optimal Levothyroxine Administration Strategy
Standard Morning Dosing Protocol
Take levothyroxine 30–60 minutes before breakfast on an empty stomach to maximize absorption, as gastric acidity is essential for adequate absorption 4, 1, 5
Wait at least 4 hours after levothyroxine before taking calcium, iron, antacids, or proton pump inhibitors to prevent binding and absorption interference 1
Alternatively, take potentially interacting medications at least 1 hour before levothyroxine if morning dosing of multiple medications is necessary 2
Alternative Dosing Options
Bedtime administration (at least 2–3 hours after the last meal) is an acceptable alternative that may improve TSH suppression and increase free T4 levels compared to morning dosing 6, 7
Liquid levothyroxine formulations may be taken during breakfast in patients with compliance issues, as they demonstrate improved absorption compared to tablets even when taken with food 5
Soft-gel capsule formulations provide 30–50% better absorption than tablets in patients on proton pump inhibitors; monitor TSH 6–8 weeks after switching formulations to avoid overtreatment 3
Special Clinical Situations
Patients on Proton Pump Inhibitors
Switch to liquid or soft-gel levothyroxine formulations rather than attempting strict timing separation, as PPIs reduce tablet absorption by 30–40% through pH-mediated mechanisms 3
Monitor TSH 6–8 weeks after any formulation change, as improved absorption may cause iatrogenic hyperthyroidism if dose is not adjusted 3
Patients with Gastrointestinal Disorders
Chronic GI conditions (celiac disease, inflammatory bowel disease, persistent diarrhea, bariatric surgery history) reduce levothyroxine absorption and often necessitate higher doses or alternative formulations 3
Consider liquid or soft-gel formulations in patients with documented malabsorption to bypass pH-dependent dissolution issues 5
Patients on Multiple Interacting Medications
Create a medication schedule that spaces levothyroxine at least 4 hours from all interacting agents; bedtime levothyroxine dosing often simplifies this separation 2, 1, 6
Review all new medications when TSH becomes elevated despite stable levothyroxine dose, as newly initiated interacting drugs are a common cause of absorption interference 3
Critical Monitoring Parameters
After Starting or Changing Interacting Medications
Recheck TSH and free T4 in 6–8 weeks after initiating calcium, iron, PPIs, or other interacting medications to detect absorption interference 4
Increase levothyroxine dose by 12.5–25 mcg if TSH rises above target range (0.5–4.5 mIU/L) after starting interacting medications 4
Long-Term Management
Monitor TSH every 6–12 months once stable on a consistent medication regimen with proper timing separation 4
Reassess medication timing and formulation if TSH becomes difficult to control despite dose adjustments 3
Common Pitfalls to Avoid
Never assume tablet levothyroxine will be adequately absorbed in patients on chronic PPI therapy; switch to liquid or soft-gel formulations rather than increasing tablet dose indefinitely 3
Do not overlook recent medication changes when evaluating unexplained TSH elevation; new calcium, iron, or PPI therapy is a frequent culprit 3, 1
Avoid taking levothyroxine with coffee, as it may reduce absorption even when other interacting medications are properly separated 5
Do not assume all levothyroxine formulations are bioequivalent; liquid and soft-gel capsules have superior absorption profiles in patients with malabsorption or on PPIs 3, 5